Search results: Found 15

Listing 1 - 10 of 15 << page
of 2
>>
Sort by
Towards a molecular classification of colorectal cancer

Author:
Book Series: Frontiers Research Topics ISSN: 16648714 ISBN: 9782889195671 Year: Pages: 62 DOI: 10.3389/978-2-88919-567-1 Language: English
Publisher: Frontiers Media SA
Subject: Oncology --- Medicine (General)
Added to DOAB on : 2016-02-05 17:24:33
License:

Loading...
Export citation

Choose an application

Abstract

In 2007, Jeremy Jass proposed a molecular classification of colorectal cancer including KRAS, BRAF, Mismatch Repair, CIMP and MGMT Status. Since then, many prognostic and predictive studies have been published on this topic, mainly focusing on one single molecular marker. The aim of the e-book is to summarize the knowledge in 2014 from a multidisciplinary point of view that can potentially be used as a manual by CRC researchers in every field.

MicroRNA as Biomarkers in Cancer Diagnostics and Therapy

Author:
ISBN: 9783039212491 9783039212507 Year: Pages: 166 DOI: 10.3390/books978-3-03921-250-7 Language: English
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Science (General) --- Biology --- Microbiology
Added to DOAB on : 2019-08-28 11:21:27
License:

Loading...
Export citation

Choose an application

Abstract

This Special Issue celebrates the 25th anniversary of the discovery of the first microRNA. The size of the microRNome and complexity of animal body plans and organ systems suggests a role for microRNAs in cell fate determination and differentiation. More than 2000 sequences have been proposed to represent unique microRNA genes in humans, with an increasing number of mechanistic roles identified in developmental, physiological, and pathological processes. Thus, dysregulation of a few key microRNAs can have a profound global effect on the gene expression and molecular programs of a cell. This great potential for clinical intervention has captured the interest and imagination of researchers in many fields. However, very few fields have been as prolific as the field of cancer research. This Special Issue provides but a glimpse of the large body of literature of microRNA biology in cancer research, containing 4 original research studies and 4 review articles that focus on specific hematologic or solid tumors in disease. Collectively, these articles highlight state-of-the-art approaches and methodologies for microRNA detection in tissue, blood, and other body fluids in a range of biomarkers applications, from early cancer detection to prognosis and treatment response. The articles also address some of the challenges regarding clinical implementation.

Natural Compounds as New Cancer Treatments

Author:
ISBN: 9783039213658 9783039213665 Year: Pages: 128 DOI: 10.3390/books978-3-03921-366-5 Language: English
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Medicine (General)
Added to DOAB on : 2019-12-09 11:49:15
License:

Loading...
Export citation

Choose an application

Abstract

Cancer remains one of the main causes of morbidity and mortality worldwide. Although many pharmacological and clinical advances have been made, there is a constant need for new molecules to improve the overall options for treatment. Natural compounds from animal, microbial, vegetal, or fungal origin represent countless sources of new compounds that can be used as anticancer drugs, provided their activity, bioavailability, and toxicity are adequate. This book aims to compile both original articles and reviews that cover the most recent advances in the use of natural compounds for cancer treatment, and provide new objectives and advice for future research in the field of biological activity of natural compounds.

microRNA Regulation in Health and Disease

Authors: ---
ISBN: 9783039217144 9783039217151 Year: Pages: 154 DOI: 10.3390/books978-3-03921-715-1 Language: English
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Science (General) --- Biology --- Genetics
Added to DOAB on : 2020-04-07 23:07:08
License:

Loading...
Export citation

Choose an application

Abstract

MicroRNAs (miRNAs) are small regulatory RNAs that play a crucial role in posttranscriptional gene regulation. Over two thousand miRNAs have been identified in humans, and many of them are conserved in other species. miRNAs are implicated in fundamental cellular functions, including development and disease. In the last decade, there has been an overwhelming amount of data contributing to the understanding of miRNA biogenesis and their target genes. Moreover, a significant amount of work has been carried out in developing miRNA biomarkers and therapeutics for various disease conditions. RNA-based markers and therapeutics have been proven to have a clinical impact, and many of these miRNA-based therapies are at various stages of human clinical trials and clinical applications. Notably, miRNAs are also found in exosomes, and are considered to impart intercellular communication and function via several different modalities, including tunneling nanotubes. In spite of our understanding of miRNA biology and function, there are many challenges in effectively using miRNAs as biomarkers and therapeutic agents in clinical applications. In this Special Issue, we are inviting reviews, perspectives, and original research articles to address some of these challenges. Topics will include, but are not limited to, miRNA biogenesis, clinical applications, extracellular function, biomarkers, miRNA immune regulation, signaling pathways, and preclinical models.

Nutrition in Inflammatory Bowel Disease (IBD)

Author:
ISBN: 9783039214396 9783039214402 Year: Pages: 370 DOI: 10.3390/books978-3-03921-440-2 Language: English
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Science (General) --- Biology --- Nutrition and Food Sciences
Added to DOAB on : 2019-12-09 11:49:15
License:

Loading...
Export citation

Choose an application

Abstract

The purpose of this Special Issue “Nutrition in Inflammatory Bowel Disease (IBD)” is to increase knowledge regarding the role of dietary composition and effects in IBD, describing the prevalence of malnutrition in IBD and the effect on clinical outcomes, discussing methods of nutrition risk screening and assessment in IBD, and reviewing mechanisms through which diet and dietary components may affect disease severity. The articles focus on the following areas: Dietary Composition/Therapy Interventions in Ulcerative Colitis and effects on outcomes; Dietary Composition/Therapy Interventions in Crohn’s Disease and effects on outcomes; Nutrition Risk Screening and Assessment in IBD; Mechanisms of Diet in the pathogenesis of IBD.

Keywords

body composition --- obesity --- visceral adipose tissue --- fat --- osteoporosis --- osteopenia --- sarcopenia --- inflammatory bowel disease --- Crohn’s disease --- dietary intake --- malnutrition --- Mediterranean diet --- exclusive enteral nutrition --- children --- IBD --- remission --- mucosal cytokines --- dietary protein level --- colitis --- epithelial repair --- mucosa-adherent microbiota --- intestinal inflammation --- inflammatory bowel disease --- epithelial adherens junctions --- bioactive peptides --- synbiotic --- prebiotic --- probiotic --- IBD --- Bacillus spores --- dietary fibre --- sugar cane fibre --- ulcerative colitis --- colon --- high-sulfur foods --- inflammation --- metagenomics --- microbiota --- sulfur reducing --- inflammatory bowel disease --- Crohn --- ulcerative colitis --- diet --- nutrition --- exclusive enteral nutrition --- intestinal epithelial cells --- inflammation --- probiotics --- Lactobacillus acidophilus --- Bifidobacterium animalis subsp. lactis --- vitamin D --- IBD --- Crohn’s disease --- ulcerative colitis --- supplementation --- deficiency --- Inflammatory Bowel Disease (IBD) --- Mediterranean Diet --- Western-style Diet (WSD) --- Nutritional Approach --- vitamin D --- Crohn’s disease --- ulcerative colitis --- faecal calprotectin --- C-reactive protein --- diet --- inflammatory bowel disease --- microbiota --- intestinal barrier --- nutrients --- immunity --- colitis --- food additive --- diet --- emulsifiers --- high salt diet --- inflammatory bowel diseases --- inflammatory bowel disease --- dietary modification --- exclusive enteral nutrition --- lifestyle modification --- Mediterranean diet --- colorectal cancer --- inflammatory bowel disease --- colorectal cancer --- dysplasia --- berries --- chemoprevention --- Inflammatory Bowel Disease --- micronutrients --- vitamin --- mineral --- deficiency --- inflammatory bowel disease --- dietary habits --- food components --- gut microbiota --- immune homeostasis --- epigenetic changes --- inflammatory bowel disease --- malnutrition --- Mediterranean diet --- older age --- diet --- inflammatory bowel disease --- ulcerative colitis --- inflammatory bowel disease --- Westernisation --- genotypes --- nutrient deficiency --- food intolerance --- FODMAPs --- gluten --- fructose --- lactose --- brassica --- mushrooms --- n/a

Cancer Biomarkers and Targets in Digestive Organs

Authors: ---
ISBN: 9783039214631 9783039214648 Year: Pages: 146 DOI: 10.3390/books978-3-03921-464-8 Language: English
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Medicine (General)
Added to DOAB on : 2019-12-09 11:49:15
License:

Loading...
Export citation

Choose an application

Abstract

Identification and development of cancer biomarkers and targets have greatly accelerated progress towards precision medicine in oncology. Studies of tumor biology have not only provided insights into the mechanisms underlying carcinogenesis, but also led to discovery of molecules that have been developed into cancer biomarkers and targets. Multi-platforms for molecular characterization of tumors using next-generation genomic sequencing, immunohistochemistry, in situ hybridization, and blood-based biopsies have greatly expanded the portfolio of potential biomarkers and targets. These cancer biomarkers have been developed for diagnosis, early detection, prognosis, and prediction of treatment response. The molecular targets have been exploited for anti-cancer therapy and delivery of therapeutic agents. This Special Issue of Biomedicines focuses on recent advances in the discovery, characterization, translation, and clinical application of cancer biomarkers and targets in malignant diseases of the digestive system. The goal is to stimulate basic and translational research and clinical collaboration in this exciting field with the hope of developing strategies for prevention and early detection/diagnosis of cancer in digestive organs, and improving therapeutic and psychosocial outcomes in patients with these malignant diseases.

Keywords

colorectal cancer --- intestinal disorder --- intestinal tumors --- zebrafish --- stereotactic body radiation therapy --- immunotherapy --- biomarkers --- Asian Cancer Research Group (ACRG) --- gastric carcinoma --- molecular profiling --- precision therapy --- pembrolizumab --- predictive biomarkers --- ramucirumab --- The Cancer Genome Atlas (TCGA) --- therapeutic targets --- trastuzumab --- biliary tract carcinoma --- chemotherapy --- clinical trial --- colorectal carcinoma --- gastric carcinoma --- gastrointestinal oncology --- hepatocellular carcinoma --- immunotherapy --- pancreatic carcinoma --- targeted therapy --- Liver transplantation --- liver graft injury --- intragraft gene expression profiles --- cell adhesion molecules --- CD274 --- HFE --- hepatocellular carcinoma --- immunohistochemistry --- molecular profiling --- next-generation sequencing --- precision medicine --- predictive biomarkers --- gastrointestinal oncology --- pancreatic carcinoma --- hepatocellular carcinoma --- biliary tract carcinoma --- gastric carcinoma --- colorectal carcinoma --- stereotactic body radiation therapy --- liver transplant --- targeted therapy --- psychosocial support --- G protein–coupled receptors --- cholecystokinin --- gastrin --- gastrin-releasing peptide --- bombesin --- neurokinin --- neurotensin --- somatostatin --- circulating tumor cells --- colorectal carcinoma --- CAM invasion assay --- phenotypic mosaics --- tumor progenitor --- biomarker --- gastrointestinal malignancies --- immunotherapy --- n/a

Coffee and Caffeine Consumption for Human Health

Author:
ISBN: 9783039286287 / 9783039286294 Year: Pages: 290 DOI: 10.3390/books978-3-03928-629-4 Language: eng
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Science (General) --- Biology --- Nutrition and Food Sciences
Added to DOAB on : 2020-06-09 16:38:57
License:

Loading...
Export citation

Choose an application

Abstract

The year 2019 has been prolific in terms of new evidence regarding the effects of coffee and caffeine consumption on diverse aspects of human functioning. This book collects 20 high-quality manuscripts published in Nutrients that include original investigation or systematic review studies of the effects of caffeine intake on human performance and health. The diversity of the articles published in this Special Issue highlights the extent of the effects of coffee and caffeine on human functioning, while underpinning the positive nature of most of these effects. This book will help with understanding why the natural sources of caffeine are so widely present in the nutrition behaviors of modern society.

Keywords

pharmacokinetics --- energy drink --- exercise --- elite athlete --- performance --- football --- RPE --- DOMS --- sport performance --- supplementation --- ergogenic aids --- consumer --- behavior --- perception --- coffee --- health --- consumption motives --- coffee/caffeine --- systematic review and meta-analysis --- prospective studies --- epidemiology --- cancer prevention --- colorectal cancer --- individual responses --- responders --- exercise performance --- ergogenic aids --- caffeine --- coffee --- tea --- energy drinks --- pregnancy --- newborn --- caffeine --- ergogenic aid --- resistance training --- isokinetic testing --- adrenal gland --- caffeine --- corticosterone --- puberty --- rat --- sex-difference --- caffeine --- energy drinks --- fatigue --- mood state --- exercise --- supplement --- resistance exercise --- speed --- repetition --- n/a --- metabolome --- skeletal muscle --- exercise --- muscle contraction --- ergogenic effect --- bench press --- upper limb --- resistance exercise --- ergogenic substances --- time under tension --- 1RM test --- caffeine --- metabolites --- phenotyping --- CYP450 --- NAT --- xanthine oxidase --- actigraphy --- athletic --- coffee --- ergogenic aid --- supplement --- anaerobic --- caffeine --- CMJ --- ergogenic aids --- exercise --- nutrition --- sport supplement --- Wingate --- electromyography --- efficiency --- sport --- exercise --- expectancy --- belief --- perceptions --- placebo effect --- recovery --- strength --- power --- sprint performance --- menstrual cycle --- fatigue --- placebo --- ergogenic --- EEG–EMG coherence --- n/a --- women --- resistance exercise --- exercise training --- velocity --- ergogenic aid --- muscle function --- n/a

Characterization of Bioactive Components in Edible Algae

Author:
ISBN: 9783039285600 / 9783039285617 Year: Pages: 226 DOI: 10.3390/books978-3-03928-561-7 Language: eng
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Science (General) --- Biology --- Nutrition and Food Sciences
Added to DOAB on : 2020-06-09 16:38:57
License:

Loading...
Export citation

Choose an application

Abstract

Algae have been used since ancient times as food for humans, animal feed, agricultural fertilizer, and as a source of substances for therapeutic use. Currently, seaweed represents a vast source of raw materials used in the pharmaceutical, food, traditional medicine, and cosmetics industries. They are nutritionally valuable, both fresh and dried, or as ingredients in a wide variety of pre-made foods. In particular, seaweed contains significant amounts of protein, lipids, minerals, and vitamins. Information is limited on the role of algae and their metabolites in therapy. Only a few taxa have been studied for use in medicine. Many traditional cultures report the healing powers of selected algae in tropical and subtropical marine forms. This is especially true in the maritime areas of Asia, where the sea plays a significant role in daily activities. However, currently, only a few genera and species of algae are involved in aspects of medicine and therapy. The beneficial uses of seaweed or seaweed products include those that can mimic specific manifestations of human disease, production of antibiotic compounds, or improved human nutrition.

Application of Bioinformatics in Cancers

Author:
ISBN: 9783039217885 9783039217892 Year: Pages: 418 DOI: 10.3390/books978-3-03921-789-2 Language: English
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Technology (General) --- Biotechnology
Added to DOAB on : 2019-12-09 11:49:16
License:

Loading...
Export citation

Choose an application

Abstract

This collection of 25 research papers comprised of 22 original articles and 3 reviews is brought together from international leaders in bioinformatics and biostatistics. The collection highlights recent computational advances that improve the ability to analyze highly complex data sets to identify factors critical to cancer biology. Novel deep learning algorithms represent an emerging and highly valuable approach for collecting, characterizing and predicting clinical outcomes data. The collection highlights several of these approaches that are likely to become the foundation of research and clinical practice in the future. In fact, many of these technologies reveal new insights about basic cancer mechanisms by integrating data sets and structures that were previously immiscible.

Keywords

comorbidity score --- mortality --- locoregionally advanced --- HNSCC --- curative surgery --- traditional Chinese medicine --- health strengthening herb --- cancer treatment --- network pharmacology --- network target --- high-throughput analysis --- brain metastases --- colorectal cancer --- KRAS mutation --- PD-L1 --- tumor infiltrating lymphocytes --- drug resistance --- gefitinib --- erlotinib --- biostatistics --- bioinformatics --- Bufadienolide-like chemicals --- molecular mechanism --- anti-cancer --- bioinformatics --- cancer --- brain --- pathophysiology --- imaging --- machine learning --- extreme learning --- deep learning --- neurological disorders --- pancreatic cancer --- TCGA --- curation --- DNA --- RNA --- protein --- single-biomarkers --- multiple-biomarkers --- cancer-related pathways --- colorectal cancer --- DNA sequence profile --- Monte Carlo --- mixture of normal distributions --- somatic mutation --- tumor --- mutable motif --- activation induced deaminase --- AID/APOBEC --- transcriptional signatures --- copy number variation --- copy number aberration --- TCGA mining --- cancer CRISPR --- firehose --- gene signature extraction --- gene loss biomarkers --- gene inactivation biomarkers --- biomarker discovery --- chemotherapy --- microarray --- ovarian cancer --- predictive model --- machine learning --- overall survival --- observed survival interval --- skin cutaneous melanoma --- The Cancer Genome Atlas --- omics --- breast cancer prognosis --- artificial intelligence --- machine learning --- decision support systems --- cancer prognosis --- independent prognostic power --- omics profiles --- histopathological imaging features --- cancer --- intratumor heterogeneity --- genomic instability --- epigenetics --- mitochondrial metabolism --- miRNAs --- cancer biomarkers --- breast cancer detection --- machine learning --- feature selection --- classification --- denoising autoencoders --- breast cancer --- feature extraction and interpretation --- concatenated deep feature --- cancer modeling --- interaction --- histopathological imaging --- clinical/environmental factors --- oral cancer --- miRNA --- bioinformatics --- datasets --- biomarkers --- TCGA --- GEO DataSets --- hormone sensitive cancers --- breast cancer --- StAR --- estrogen --- steroidogenic enzymes --- hTERT --- telomerase --- telomeres --- alternative splicing --- network analysis --- hierarchical clustering analysis --- differential gene expression analysis --- cancer biomarker --- diseases genes --- variable selection --- false discovery rate --- knockoffs --- bioinformatics --- copy number variation --- cell-free DNA --- methylation --- mutation --- next generation sequencing --- self-organizing map --- head and neck cancer --- treatment de-escalation --- HP --- molecular subtypes --- tumor microenvironment --- Bioinformatics tool --- R package --- machine learning --- meta-analysis --- biomarker signature --- gene expression analysis --- survival analysis --- functional analysis --- bioinformatics --- machine learning --- artificial intelligence --- Network Analysis --- single-cell sequencing --- circulating tumor DNA (ctDNA) --- Neoantigen Prediction --- precision medicine --- Computational Immunology

Circulating Tumor Cells: Finding Rare Events for A Huge Knowledge of Cancer Dissemination

Author:
ISBN: 9783039286980 / 9783039286997 Year: Pages: 366 DOI: 10.3390/books978-3-03928-699-7 Language: eng
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Medicine (General)
Added to DOAB on : 2020-06-09 16:38:57
License:

Loading...
Export citation

Choose an application

Abstract

The analysis of circulating tumor cells (CTCs) as a real-time liquid biopsy approach can be used to obtain new insights into metastasis biology, and as companion diagnostics to improve the stratification of therapies and to obtain insights into the therapy-induced selection of cancer cells. In this book, we will cover all the different facets of CTCs to assemble a huge corpus of knowledge on cancer dissemination: technologies for their enrichment, detection, and characterization; their analysis at the single-cell level; their journey as CTC microemboli; their clinical relevance; their biology with the epithelial-to-mesenchymal transition (EMT); their stem-cell properties; their potential to initiate metastasis at distant sites; their ex vivo expansion; and their escape from the immune system.

Keywords

circulating tumor cells --- circulating tumor DNA --- liquid biopsy --- metastatic colorectal cancer --- FOLFIRINOX --- circulating tumor cells --- CTC --- liquid biopsy --- CTM --- CTMat --- CTC biology --- CTC capture technology --- metastasis --- circulating tumor cells (CTCs) --- hepatocellular carcinoma (HCC) --- castration resistant prostate cancer (CRPC) --- epithelial-to-mesenchymal transition (EMT) --- fibronectin --- integrin B1 --- SLUG --- major histocompatibility complex class I (MHCI) --- immunomodulation --- bone marrow --- melanoma --- disseminated tumor cells --- solid cancers --- single-cell analysis --- enrichment and detection technologies --- flow cytometry --- tumor stem cells --- HMB-45 --- CD133 --- locally advanced rectal cancer --- circulating tumor cells --- RAD23B --- thymidylate synthase --- chemoradioresistance --- liquid biopsy --- circulating tumor cells --- epithelial–mesenchymal transition --- stem cells --- early breast cancer --- prostate cancer (PCa) --- circulating tumor cells (CTC) --- liquid biopsy --- circulating tumor cells --- metastasis --- xenograft models --- breast cancer --- prostate cancer --- CTC --- AR --- AR-V7 --- ctRNA --- exosome --- circulating tumor cells --- hematological cells --- neutrophils --- platelets --- liquid biopsy --- circulating tumor cells --- melanoma --- liquid biopsy --- EPISPOT --- CellSearch® --- liquid biopsy --- CTCs --- immune checkpoint inhibitors --- PD-L1 expression --- NSCLC --- small-cell lung carcinoma --- circulating tumor cells --- microfluidics --- gene expression analysis --- synaptophysin --- chromogranin A --- rovalpituzumab tesirine --- leukocyte-derived extracellular vesicles --- immunofluorescence imaging --- EpCAM enrichment --- CellSearch --- EasyCount slides --- ACCEPT --- CTC --- heterogeneity --- liquid biopsy --- liquid surgery --- clinical utility --- circulating tumor cells (CTCs) --- glioma --- biomarker --- rVAR2 --- malaria --- enrichment and detection technologies --- prostate cancer --- biomarkers --- circulating tumor cells --- androgen receptor --- ARV7 --- abiraterone --- enzalutamide --- metastasis --- tumor-initiating cells (TICs) --- circulating tumor cells (CTCs) --- CTC-derived xenografts --- CTC-derived ex vivo models --- cerebrospinal liquid biopsy --- in vivo flow cytometry --- tumor biomarkers --- circulating tumor cells --- ctDNA --- miRNA --- exosomes --- emboli --- targeted therapy --- circulating tumor cells --- tumor cell dissemination --- immune system --- microbiome --- circulating tumor cells (CTCs) --- clinical trials --- breast cancer --- CTC-based treatment decisions --- circulating tumour cells --- colorectal cancer --- colorectal surgery --- microsatellite instability --- microfluidics --- immunophenotyping --- fish --- liquid biopsy --- circulating leukemia cells --- circulating plasma cells --- n/a

Listing 1 - 10 of 15 << page
of 2
>>
Sort by
Narrow your search